Worldwide: Life Sciences, Biotechnology & Nanotechnology

Subscribe
Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.
Article
The Critical First 30 Days: A Defense Perspective On Managing Traumatic Accident Claims
When an accident occurs on your property, the first 30 days can determine the outcome of any litigation. Seasoned trial attorneys explain why immediate action—from preserving evidence to coordinating with legal counsel—is essential for building a strong defense. Learn the critical steps businesses must take in those crucial first hours and weeks to protect their interests and ensure claims are based on facts rather than incomplete evidence.
United States Litigation
BI
Buchanan Ingersoll & Rooney PC
Article
FDA Approves First Gene Therapy For Rare Pediatric Immune Disorder Severe Leukocyte Adhesion Deficiency Type I
The FDA has approved Kresladi, a groundbreaking gene therapy that uses patients' own genetically modified blood stem cells to treat severe Leukocyte Adhesion Deficiency Type I, a rare inherited immune disorder that leaves children vulnerable to life-threatening infections. This first-of-its-kind treatment offers an alternative to risky blood stem cell transplants, particularly for patients without matched sibling donors.
United States Healthcare
GP
Goodwin Procter LLP
Article
CMS Finalizes CY 2027 Medicare Advantage And Part D Rule: Key Implications For Plan Sponsors
The Centers for Medicare & Medicaid Services has published its final rule governing Medicare Advantage and Prescription Drug Benefit programs for Contract Year 2027, implementing a broad deregulatory agenda that reverses marketing safeguards while restructuring Star Ratings measures and codifying Inflation Reduction Act-mandated benefit changes. The rule eliminates enrollment protections introduced in 2023, reduces documentation requirements, and shifts quality measurement weight toward survey-based categor
United States Healthcare
CM
Crowell & Moring LLP
See more